cyanosulfoxylate

Small moleculeexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2015 (NCT02598999)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • cyanosulfoxylate
  • hypothiocyanite
  • hypothiocyanite
  • hypothiocyanite
  • hypothiocyanite ion
  • oscn-

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02598999Phase 1Nov 1, 2015Eurofins, STRAGEN
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
EurofinsFor profit1012015
STRAGENFor profit1112015
2 organizations
Page 1 / 1